
Stockholm – A synthetic drug akin to khat is becoming more prevalent in Europe’s drug market. The EU’s drug agency, EUDA, has issued a warning about an “unprecedented” rise in imports and seizures.
In contrast to khat, a natural substance that contains cathinone and impacts the central nervous system similarly to amphetamines, the cathinones that EUDA is alerting about are chemically manufactured.
In 2023, the latest year covered in EUDA’s annual report for 2025, the imports and seizures of synthetic cathinones were three times greater than the total of amphetamine and methamphetamine seizures in Europe. The total amount of seizures surged from 4.5 tons in 2021 to 37 tons in 2023.
Significant quantities are thought to be entering via India through the Netherlands, and 53 production sites were identified in EU countries in 2023, including one in Sweden.
(June 6)
Leave a Reply